Package 76420-279-90

{"route": ["ORAL"], "spl_id": "e838b0d0-6869-8c20-e053-2a95a90a4d11", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["151226", "199888", "199889", "199890"], "spl_set_id": ["4e476c33-3590-4c6f-981d-915623cdacf0"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (76420-279-30)", "package_ndc": "76420-279-30", "marketing_start_date": "20220909"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (76420-279-60)", "package_ndc": "76420-279-60", "marketing_start_date": "20220909"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (76420-279-90)", "package_ndc": "76420-279-90", "marketing_start_date": "20220909"}], "brand_name": "Topiramate", "product_id": "76420-279_e838b0d0-6869-8c20-e053-2a95a90a4d11", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "76420-279", "generic_name": "Topiramate", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "100 mg/1"}], "application_number": "ANDA076343", "marketing_category": "ANDA", "marketing_start_date": "20140612", "listing_expiration_date": "20261231"}